Clinical and epidemiologic analysis of intestinal tract colonization with vancomycin-resistant enterococci in an intensive care unit;Análisis clínico-epidemiológico de la portación intestinal de enterococos resistentes a vancomicina en una unidad de terapia intensiva

Revista Argentina de Microbiologia

Volumn 37, Issue 1, 2005, Pages 26-33

  Togneri, A M ^a,b   Corso, A ^c   Gonzalez J ^a,b   Lopardo, H ^a   Podesta L B ^a,b   Gagetti, P ^c   Perez M ^a,b   Rodriguez V ^a,b   Rodriguez M ^c   Rios L ^a,b   Dinerstein, E ^a,b  

^a Hospital Interzonal General de Agudos Evita   (Brazil)

^b ANLIS Dr Carlos G Malbrán ^*

^c HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

Author keywords

Colonization; Enterococci; Enterococcus faecium; Enterococcus gallinarum; Resistance; Vancomycin

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CHLORAMPHENICOL; CIPROFLOXACIN; ERYTHROMYCIN; GENTAMICIN; STREPTOMYCIN; TEICOPLANIN; TETRACYCLINE; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIUM ISOLATE; DISEASE PREDISPOSITION; DISEASE TRANSMISSION; ENTEROCOCCUS; ENTEROCOCCUS FAECIUM; ENTEROCOCCUS GALLINARUM; FEMALE; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PULSED FIELD GEL ELECTROPHORESIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARGENTINA; COHORT STUDIES; COMORBIDITY; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROCOCCUS; FEMALE; GENOTYPE; HUMANS; INTENSIVE CARE UNITS; INTESTINES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TEICOPLANIN; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 21244468707     PISSN: 03257541     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Biavasco F, Paladini C, Vignaroli C, Foglia G, Manso E, Varaldo PE (2001) Recovery from a single blood culture of two Enterococcus gallinarum isolates carrying both vanC-1 and vanA cluster genes and differing in glycopeptide susceptibility. Eur. J. Clin. Microbiol. Infect. Dis. 20: 309-314.
2. Casellas JM, Tomé G, López Furst M, Rolán MJ, Aiub J, Marcoppido M, et al. (1997). Aislamiento de cepas de Enterococcus faecalis resistentes a la vancomicina en Argentina. I Congreso Internacional de Infectología y Microbiologia Clínica SADI - SADEBAC, Resumen H369, Buenos Aires, Argentina.
3. Chavers LS, Moser SA, Benjamin WH, Banks SE, Steinhauer JR, Smith AM, et al. (2003) Vancomicyn-resistant entecococci: 15 years and counting. J. Hosp. Infect. 53: 159-171.
4. nd Interscience Conference on Antimicrobial Agents and Chemotherapy. Resumen O2-A-3219, San Diego, EEUU.
5. Corso A, Faccone D, Gagetti P, Togneri A, Lopardo H, Melano R, et al. (2005) The first report of VanA Enterococcus gallinarum dissemination within an intensive care unit in Argentina. Int. J. Antimicrob. Agents 25:51-56.
6. th Interscience Conference on Antimicrobial Agents and Chemotherapy, Resumen C2-509, Chicago, EEUU.
7. De Lencastre H, Brown AE, Chung M, Armstrong D, Tomasz A (1999) Role of transposon Tn5482 in the epidemiology of vancomycin-resistant Enterococcus faecium in the pediatric oncology unit of a New York city Hospital. Microb. Drug Resist. 5: 113-128.
8. Dutka-Malen S, Blaimont B, Wauters G, Courvalin P (1994) Emergence of high-level resistance to glycopeptides in Enterococcus gallinarum and Enterococcus casseliflavus. Antimicrob. Agents Chemother. 38: 1675-1677.
9. Dutka-Malen S, Evers S, and Courvalin P (1995) Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J. Clin. Microbiol. 33: 24-27.
10. th ed. ASM Press, Washington, D. C. p. 297-305.
11. Giraffa G (2002) Enterococci from foods. FEMS Microbiol. Rev. 26:163-171.
12. Greisen K, Loeffelholz M, Purohit A, Leong D (1994) PCR primers and probes for the 16S rRN A gene of most species of pathogenic bacteria, including bacteria found in cerebrospinal fluid. J. Clin. Microbiol. 32: 335-351.
13. th Interscience Conference on Antimicrobial Agents and Chemotherapy, Resumen P-34, San Diego, EEUU.
14. Leclercq R, Derlot E, Duval J, Courvalin P (1988) Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N. Engl. J. Med. 319: 157-161.
15. Lopardo HA, Kaufman S, Lauro L, Vidal P, Buenos Aires Microbiology Network (2000) One-day prevalence study on colonization with vancomycin-resistant enterococci in intensive care units of Buenos Aires city. En: Martin DR, Tagg JR (Ed.), Streptococci and streptococcal diseases: entering the new millennium. Securacopy, New Zealand, p. 259-261.
16. Lopreto C, Viegas Caetano J, Padlog R, Sorgentini M, Bardi C, Silvestri C. (2002) Detección de Enterococcus faecium resistente a vancomicina: experiencia de dos años en un hospital de alta complejidad. Rev. Arg. Microbiol. 34: 222-225.
17. Low DE, Willey BM, Betschel S, Kreiswirth B (1994) Enterococci: pathogens of the 90s. Eur. J. Surg. (Suppl.) 573: 19-24.
18. Lu JJ, Wu JC, Chiueh TS, Perng CL, Chi WM, Lee WH (2000) Characterization of a highly glycopeptide-resistant Enterococcus gallinarum isolate. J. Formos. Med. Assoc. 99: 305-310.
19. Marín E, Mera JR, Arduino RC, Correa AP, Coque TM, Stamboulian D, et al. (1998) First report of vancomycin-resistant Enterococcus faecium isolated in Argentina. Clin. Infect. Dis. 26: 235-236.
20. Miranda G, Corso A, Melano R, Arismendi P, Rodríguez M, Garbewetsky L. (2003) Primer aislamiento de Enterococcus faecium vancomicina - resistente con genotipo vanB en la Argentina: presentación de dos casos. Rev. Arg. Microbiol. 35: 41-44.
21. National Committee for Clinical Laboratory Standards (2002). Performance standards for antimicrobial susceptibility testing: Twelfth informational supplement. Document M100-S12. National Committee for Clinical Laboratory Standards. Wayne, Pennsylvania, USA.
22. Oguri T, Misawa S, Nakamura A, Igari J, Ishi Y, Yamaguchi K (2001) Epidemiological study on vancomycin-resistant enterococci from fecal samples in the east area of Japan. Kansenshogaku Zasshi. 75: 541-550.
23. Ostrowsky BE, Venkataraman L, D'Agata EMC, Gold HS, de Girolami PC, Samore MH (1999) Vancomycin-resistant enterococci in intensive care units. Arch. Intern. Med. 159: 1467-1472.
24. Podestá OS, Mera JR, Marin ME, Galdón F, Correa AP, Stamboulian D, et al. (1997) Brote de enterococo resistente a la vancomicina (EVR) en un servicio de clínica médica en un hospital en Mendoza. I Congreso Internacional de Infectología y Microbiología Clínica SADI - SADEBAC, Resumen H332, Buenos Aires, Argentina.
25. Reid KC, Cockerill III IF, Patel R (2001) Clinical and epidemiological features of Enterococcus casseliflavus/ flavescens and Enterococcus gallinarum bacteremia: a report of 20 cases. Clin. Infect. Dis. 32: 1540-1546.
26. Rice LB (2001) Emergence of vancomycin-resistant enterococci. Emerg. Infect. Dis. 7: 183-187.
27. Targa L, Carbone E, Gallego V, Podestá OS, Marín M, Arduino R (1997) Brote epidémico por Enterococcus faecium resistente a la vancomicina en un hospital de Buenos Aires. I Congreso Internacional de Infectología y Microbiología Clínica SADI- SADEBAC, Resumen H330, Buenos Aires, Argentina.
28. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, et al. (1995) Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33: 2233-2239.
29. Vergis EN, Hayden MK, Chow JW, Snydman DR, Zervos MJ, Linden PK, et al. (2001) Determinants of vancomycin resistance mortality rates in enterococcal bacteremia: a prospective multicenter study. Ann. Intern. Med. 135: 484-492.
30. Yoshimoto E, Konishi M, Takahashi K, Majima T, Ueda K, Murakawa K, et al. (1999) Enterococcus gallinarum septicemia in a patient with acute myeloid leukemia. Kansenshogaku Zasshi 73: 1078-1081.
31. Zhanel GG, Harding GK, Rosser S, Hoban DJ, Karlowsky JA, Alfa M, et al. (2000) Low prevalece of EVR gas-trointestinal colonization of hospitalized patients in Manitoba tertiary care and community hospitals. Can. J. Infect. Dis. 10: 340-344.